Comparison of Outcomes Between SBRT, Yittrium-90 Radioembolization, Transarterial Chemoembolization, and Radiofrequency Ablation as Bridge to Transplant for Hepatocellular Carcinom... von Mohamed, M.R, Qiu, H.C, Tejani, M.A, Noel, M.S, Kashyap, R, Sharma, A, Hezel, A.F, Katz, A.W

Volltext

425P Updated results of induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally advanced esophageal and gastroesophageal junction cancer: A phase II... von Gim, G., Zhao, J., Badri, N.J., McGreevy, M., Noel, M.S., Baran, A.M., Wang, W., Ramsdale, E.E., Zittel, J., Mulkerin, D.L., Qiu, H., Katz, A.W., Huber, A.R., Jones, C.E., Peyre, C.G., Lada, M.J., Feingold, P.L., Hezel, A.F., Tejani, M.A., Dunne, R.F.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B H, Scott, A J, Ma, W W, Cohen, S J, Aisner, D L, Menter, A R, Tejani, M A, Cho, J K, Granfortuna, J, Coveler, L, Olowokure, O O, Baranda, J C, Cusnir, M, Phillip, P, Boles, J, Nazemzadeh, R, Rarick, M, Cohen, D J, Radford, J, Fehrenbacher, L, Bajaj, R, Bathini, V, Fanta, P, Berlin, J, McRee, A J, Maguire, R, Wilhelm, F, Maniar, M, Jimeno, A, Gomes, C L, Messersmith, W A

Volltext

Early results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + pembrolizumab therapy in patients (Pts) with relapsed/refractory gastric/gastroesophageal junction (GEJ) adenocarcinoma von Harvey, R.D., Murphy, A., Kim, E., Tejani, M.A., Wu, W., Pham, E.L., Muhsin, M.

Volltext

Safety And Efficacy Of Short-Course Preoperative Stereotactic Body Radiation Therapy For Resectable Pancreatic Cancer: A Prospective Clinical Trial von Qiu, H.C., Schoeniger, L.O., Dunne, R., Linehan, D.C., Kaul, V., Tejani, M.A., Galka, E., Noel, M., Kothari, S., Hezel, A.F., Ramsdale, E.E., Katz, A.W.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, A.L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Leichman, L., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.

Volltext